Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
CABA
CABA
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
CABA News
Cabaletta Bio (CABA) Shares Surge 11% Following Insider Purchases
Jan 22 2026
seekingalpha
High Roller Technologies Inc Closes Direct Offering, Raises $25 Million
Jan 22 2026
Benzinga
IO Biotech (IOBT) Explores Strategic Alternatives, Stock Surges 19.36%
Jan 22 2026
NASDAQ.COM
Cabaletta Bio (CABA) Shares Rise Nearly 6% on Clinical Progress
Jan 20 2026
NASDAQ.COM
FDA's Strict Stance Creates Uncertainty for uniQure's Fast-Tracked Huntington's Gene Therapy
Nov 04 2025
Benzinga
Top Analysts Recommend 3 Best Stocks to Purchase Now, 10/10/2025
Oct 10 2025
TipRanks
HC Wainwright & Co. Affirms Buy Rating for Cabaletta Bio, Keeps $16 Price Target Intact
Oct 10 2025
Benzinga
Cabaletta Bio Unveils Initial Rese-cel Data Without Preconditioning, Showcasing Biological Activity and Early Clinical Responses at the 2025 ESGCT Annual Congress
Oct 09 2025
Newsfilter
PRFZ's Holdings May Offer 13% Profit Potential
Sep 23 2025
NASDAQ.COM
Cabaletta Bio to Attend Investor Conferences Scheduled for September
Aug 27 2025
Newsfilter
Cabaletta Bio (CABA) Upgraded to Buy: Here's Why
Aug 11 2025
NASDAQ.COM
Cabaletta Bio (CABA) Q2 Loss Widens 30%
Aug 07 2025
NASDAQ.COM
Cabaletta Bio files $240M mixed securities shelf
Aug 07 2025
SeekingAlpha
What's Going On With Sarepta, Capricor And Other Gene Therapy Stocks On Wednesday?
Jul 30 2025
Benzinga
FDA Eases Access To Life-Saving Gene Therapies For Blood Cancers
Jun 30 2025
Benzinga
Cabaletta Bio Launches Public Offering Of Stock And Warrants
Jun 12 2025
NASDAQ.COM
Show More News
